Global Veterinary Rehabilitation Services Market is poised for remarkable expansion, anticipating a CAGR of 9.06% spanning from 2023 to 2033

Posted on 2024-04-01 by Future Market Insights in Healthcare // 0 Comments

The global veterinary rehabilitation services market is experiencing a significant boom, driven by a growing focus on pet wellness and a surge in pet ownership worldwide. According to a recent market analysis, the market demand reached US$ 792.5 million in 2022 and is projected to hit US$ 882 million in 2023. This momentum is expected to continue, with the market forecast to reach a staggering US$ 2.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of 9.06%.

This surge in demand is attributed to a growing awareness among pet owners regarding the importance of holistic care for their furry companions. More and more pet parents are recognizing the benefits of post-operative rehabilitation for their animals, leading to a significant expansion of the veterinary rehabilitation services market.

Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-15946

In recent years, there has been a notable shift in pet owners’ attitudes toward healthcare for their furry friends. The increasing awareness about the benefits of veterinary rehabilitation, coupled with the advancements in medical technologies and treatment modalities, has revolutionized the landscape of pet care.

The primary goal of veterinary rehabilitation services is to restore and maintain optimal physical function, alleviate pain, and improve the overall quality of life for animals. These services encompass a wide range of therapeutic techniques, including physical therapy, hydrotherapy, acupuncture, chiropractic care, and more. With a multidisciplinary approach, veterinarians and rehabilitation specialists collaborate to develop personalized treatment plans tailored to each patient’s unique needs.

Key Takeaways:

The Veterinary Rehabilitation Services Industry was valuation of US$ 882 Million in 2023 and it will reach an impressive valuation of US$ 2.1 billion while exhibiting a CAGR of 9.06% by 2033.
Pet humanization trends and increasing pet expenditure are augmenting the growth of the veterinary rehab service market.
By Animal type, the companion animal segment is expected to dominate the market with a 70% revenue share by 2033.
By therapy type, the therapeutic exercises segment is expected to generate the highest revenue during the forecast period.
By Indication type, Post surgery segment accounted for a market share of 31% in 2022 and is anticipated to lead the segment by the end of the forecast period.
By End-use, Veterinary rehab centers dominated the market with a 45.8 % segment share in 2022.
APAC will exhibit the highest CAGR of 13% in the veterinary rehab service market in the upcoming years.

“The market’s expansion may be linked to a paradigm shift toward workflows and process automation across a wide range of businesses and industrial verticals. Enterprises all over the world are eager to embrace effective and smooth business processes that can be executed regardless of location, which is propelling this industry ahead.” comments a Future Market Insights analyst

Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15946

Competitive Landscape:

Some of the major company profiles included in the global Veterinary Rehabilitation Services Industry report are-

Back on Track Veterinary Rehabilitation Center, LLC
Animal Acupuncture and Rehabilitation Center
BARC
Treasure Coast Animal Rehab & Fitness
Animal Rehab Center of Michigan
Blue Springs Animal Rehabilitation Center
Essex Animal Hospital
Triangle Veterinary Referral Hospital
Butterwick Animal Rehab Clinic Ltd
Animal Rehab and Conditioning Center

In April 2022, the FDA approved Vatinoxan hydrochlorides and Medetomidine injections for dogs undergoing specific clinical examinations and procedures and minor surgical operations. Medetomidine is a synthetic drug used as a surgical anesthetic and an analgesic. Vatinoxan brings down the adverse cardiovascular effects of medetomidine by maintaining the heart rate in the normal range, thus improving the cardiovascular function and the safety profile of medetomidine while the dog is sedated. Zenalpha is aimed to provide sedation and relief of pain that lasts for the duration of the sedation to dogs for clinical examinations or procedures which require the dog to remain still, calm or quiet.
In January 2022, the US FDA provided approval to Elanco Animal Health’s Zorbium which is a (buprenorphine transdermal solution). Due to this approval, veterinarians now have another alternative for managing postoperative pain in cats, owing to this approval.

Get Exclusive Purchase Now to Access: https://www.futuremarketinsights.com/checkout/15946

Key Segments Profiled in the Veterinary Rehabilitation Services Industry Survey:

By Animal Type:

Companion Animals
Wildlife Animals
Production Animals

By Therapy Type:

Therapeutic Exercises
Manual Therapy
Hydrotherapy
Hot & Cold Therapies
Electrotherapies
Acupuncture
Shockwave Therapy
Other Therapies

By Indication:

Post-Surgery
Traumatic Injuries
Acute & Chronic Diseases
Developmental Abnormalities
Other Indications

By End Use:

Veterinary Rehab Centers & Hospitals
Rescue & Shelter Homes
Rehab Sanctuary
Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick